Literature DB >> 9057522

Benign and malignant portal vein thrombosis: differentiation by CT characteristics.

M E Tublin1, G D Dodd, R L Baron.   

Abstract

OBJECTIVE: The purpose of this study was to determine if unique characteristics revealed by CT can allow radiologists to reliably distinguish benign from malignant portal vein thrombus (PVT) in patients with cirrhosis.
MATERIALS AND METHODS: CT examinations of 58 patients with cirrhosis and PVT were retrospectively reviewed. Images were assessed for location, extent, enhancement, neovascularity, and maximal diameter of PVT. The type of PVT was proven histologically in 42 patients and clinically in the remaining 16 patients. Using different threshold PVT diameters or the presence of PVT neovascularity, we calculated the sensitivity and specificity of CT for revealing malignant PVT.
RESULTS: Forty-seven patients had malignant and 11 patients had benign PVT. CT scans of patients with malignant PVT showed direct extension of hepatocellular carcinoma into the portal vein in 15 patients. In 29 patients with malignant PVT, CT scans showed PVT adjacent to tumor; CT scans showed tumor PVT remote from hepatocellular carcinoma in the remaining three patients with malignant PVT. The mean diameters of malignant and benign portal vein thrombi were significantly different (23.4 mm versus 16 mm; p = .0001). CT scans of 83% (39/47) of patients with malignant PVT and 18% (2/11) of patients with benign PVT showed generalized enhancement. Neovascularity was seen on CT scans in 43% (20/47) of patients with malignant PVT and in no patient with benign PVT. Identification of a main PVT diameter greater than or equal to 23 mm or PVT neovascularity resulted in a sensitivity and specificity for the CT characterization of malignant PVT of 86% and 100%, respectively.
CONCLUSION: Malignant and benign thrombi can often be differentiated by radiologists on the basis of CT imaging characteristics.

Entities:  

Mesh:

Year:  1997        PMID: 9057522     DOI: 10.2214/ajr.168.3.9057522

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  57 in total

1.  Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI?

Authors:  Honsoul Kim; Mi-Suk Park; Jin Young Choi; Young Nyun Park; Myeong-Jin Kim; Kyung Sik Kim; Jin Sub Choi; Kwang-Hyub Han; EunJu Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

2.  Controversies in imaging of hepatocellular carcinoma: multidetector CT (MDCT).

Authors:  Paul M Silverman; Janio Szklaruk
Journal:  Cancer Imaging       Date:  2005-12-10       Impact factor: 3.909

3.  Evaluation of hepatocellular carcinoma with portal vein tumor thrombosis by CEUS before and after hepatic arterial infusion chemotherapy.

Authors:  Hiroyuki Kirikoshi; Satoru Saito; Norio Ueno; Kaori Suzuki; Hirokazu Takahashi; Masato Yoneda; Koji Fujita; Atsushi Nakajima
Journal:  J Med Ultrason (2001)       Date:  2010-04-10       Impact factor: 1.314

4.  Follow-up results of acute portal and splenic vein thrombosis with or without anticoagulation therapy after hepatobiliary and pancreatic surgery.

Authors:  Chan Woo Cho; Yang Jin Park; Young-Wook Kim; Sung Ho Choi; Jin Seok Heo; Dong Wook Choi; Dong-Ik Kim
Journal:  Ann Surg Treat Res       Date:  2015-03-26       Impact factor: 1.859

Review 5.  Portal vein thrombosis in cirrhosis: Controversies and latest developments.

Authors:  Damian J Harding; M Thamara P R Perera; Frederick Chen; Simon Olliff; Dhiraj Tripathi
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 6.  Tumor thrombus: incidence, imaging, prognosis and treatment.

Authors:  Keith Bertram Quencer; Tamir Friedman; Rahul Sheth; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

Review 7.  Diagnosis of hepatocellular carcinoma.

Authors:  Asmaa I Gomaa; Shahid A Khan; Edward L S Leen; Imam Waked; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

Review 8.  Imaging of liver cancer.

Authors:  Ben Ariff; Claire R Lloyd; Sameer Khan; Mohamed Shariff; Andrew V Thillainayagam; Devinder S Bansi; Shahid A Khan; Simon D Taylor-Robinson; Adrian K P Lim
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

9.  Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.

Authors:  Brian I Carr; Vito Guerra
Journal:  Dig Dis Sci       Date:  2015-11-17       Impact factor: 3.199

10.  CT findings of completely regressed hepatocellular carcinoma with main portal vein tumor thrombosis after transcatheter arterial chemoembolization.

Authors:  Jeong-Hee Yoon; Hyo-Cheol Kim; Jin Wook Chung; Jung-Hwan Yoon; Hwan Jun Jae; Jae Hyung Park
Journal:  Korean J Radiol       Date:  2009-12-28       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.